Background: The Antenatal Corticosteroid Trial (ACT) assessed the feasibility, effectiveness, and safety of a multifaceted intervention to increase the use of antenatal corticosteroids (ACS) in mothers at risk of preterm birth at all levels of care in low and middle-income countries. The intervention effectively increased the use of ACS but had no overall impact on neonatal mortality in the targeted <5 th percentile birth weight infants. Being in the intervention clusters was also associated with an overall increase in neonatal deaths. We sought to explore plausible pathways through which this intervention increased neonatal mortality.
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Conclusions: The improvement in neonatal mortality in the Guatemalan site in the <5 th percentile infants was associated with a higher level of care and an improvement in care in the intervention clusters. The increase in neonatal mortality in the intervention clusters across all sites was largely driven by the poorer outcomes in the African sites, which also had an increase in pSBI in the intervention clusters. We emphasize that these results come from secondary analyses. Additional prospective studies are needed to assess the effectiveness and safety of ACS on neonatal health in low resource settings.
Trial registration: Trial registration: clinicaltrials.gov (NCT01084096)
Background
The use of antenatal corticosteroids (ACS) is believed to be among the most effective interventions to reduce neonatal mortality associated with preterm birth. However, the majority of research on its efficacy and safety has been conducted in high-resource settings [1] [2] [3] [4] [5] [6] . Few studies on ACS were conducted in low-middle income countries (LMIC) where the overwhelming majority of deaths associated with preterm birth occur [7] [8] [9] . Of those studies which have been performed outside of developed countries, several have been in Latin America, with only a few in Asia or Africa and none in the regions of the highest burden of mortality [10] [11] [12] .
The Global Network Antenatal Corticosteroid Trial (ACT), was a multi-country cluster randomized trial to assess the feasibility, effectiveness, and safety of a multifaceted intervention developed to increase the use of ACS at all levels of health care in LMICs [13, 14] . ACT, which was conducted in seven rural and semi-urban sites in subSaharan Africa, Asia and Latin America, showed that the intervention increased ACS use in the intervention clusters (46 % vs.10 % in women with <5th percentile birth weight live births), but it was not associated with a reduction in neonatal mortality in the targeted <5th percentile infants in the intervention clusters. An unexpected finding was that overall neonatal mortality was higher in intervention clusters, with the excess mortality occurring in infants born at >25th percentile site-specific birth weights.
Since ACT was a multi-country intervention, we sought to explore whether regional differences were associated with the impact of the ACS intervention. ACT was pragmatic in design and there was limited data collection beyond the primary study outcomes. Thus, the ability to identify site specific associations is limited. Nonetheless, given that ACT is the largest trial of ACS use in lowincome countries and the unanticipated results, in this paper, we further explore neonatal outcomes by site.
Methods

Specific aims
The objectives of this secondary analysis were: 1) to describe the effects of the ACT intervention on neonatal mortality, use of ACS, and possible severe neonatal bacterial infection (pSBI) by site; and 2) to assess whether the observed differences were correlated with either the use of ACS, differences in maternal characteristics or in aspects related to care.
Study design and participants
This is a secondary analysis of data collected during the ACT. The study intervention and methods are described in detail elsewhere [13] . Briefly, the ACT was a two-arm, cluster-randomized trial conducted in seven sites of the Global Network for Women's and Children's Health Research (Argentina, Guatemala, Zambia, Kenya, Pakistan, Belgaum (India) and Nagpur (India)). Clusters were organized into strata based on the 28-day neonatal mortality rate by site, and then randomized by the data center (RTI International, Durham, NC, USA). Intervention clusters received a multifaceted intervention (health provider training, posters, pregnancy discs, uterine height tape, and antenatal corticosteroids kits). Providers in the intervention clusters were trained to administer one course of four doses of 6 mg of dexamethasone every 12 h to women identified at high-risk of preterm birth. Along with providers in the formal health systems, traditional birth attendants and community health workers were also trained to identify women at risk and initiate treatment. The intervention period was 18-months, with the start date between 2011 and 2012 varying by site based on the site approval date.
Outcome data were collected by trained registry administrators in a prospective, on-going, population-based maternal and newborn health (MNH) registry independent of the intervention team. The MNH registry was implemented in 2009 [15, 16] so all sites had at least 1 year of pretrial data was available. MNH data were collected during pregnancy, following delivery and at 6-weeks postpartum to determine basic information regarding use of antenatal and delivery care, stillbirth, neonatal mortality and morbidity. Data were collected on observable infant signs of illness which were used to determine possible severe bacterial infection (pSBI) based on the World Health Organization definition, as described in detail elsewhere [ 
Statistical analyses
Generalized linear models were used to evaluate the relationship between covariates and the outcomes of interest (neonatal mortality and pSBI) and to develop point and interval estimates of relative risk (RR) associated with those risk factors. Generalized estimating equations accounted for the correlation of outcomes within cluster to develop appropriate confidence intervals. Analyses were adjusted for randomization strata. Models were log binomial when possible, otherwise Poisson models were utilized. Pre-trial data were analyzed to assess the status of various measures prior to trial implementation. All analyses were done by RTI International with SAS versions 9.3 and 9.4 (SAS Institute, Cary, NC, USA).
Ethical approvals
The trial was reviewed and approved by the ethics committees at each site. In addition, the World Health Organization and the Eunice Kennedy Shriver National Institute of Health and Human Development (NICHD) reviewed and approved the protocol. A Data Monitoring Committee reviewed the study enrollment and safety. All women provided informed consent prior to enrollment.
Results
A total of 99,742 women were enrolled in ACT across the sites including 62,541 in south Asia, 23,021 in subSaharan Africa, and 14,180 in Latin America. Basic maternal characteristics in the sites, as well as in the treatment and control clusters are presented for all sites ( Table 1 ). The percent of women who were age <20 years ranged from 1.8 % in Nagpur, India to 28.8 % in Argentina. Conversely, the percent of women age >35 years of age ranged from 0.2 % in Belgaum, India to 10.4 % in the Kenyan site. Rates of women without any formal education ranged The highest proportion of women with parity >2 was in Pakistan, where nearly 60 % of women had 2 or more prior pregnancies compared to a low of 11.2 % in the Nagpur site. Within the sites, the maternal demographics were generally similar between the intervention and control clusters. Table 2 summarizes the indicators of care for each site during the trial. Rates of women having at least one antenatal care (ANC) visit ranged from 88.4 % in Pakistan to 100 % in Belgaum. The frequency of women having > 3 ANC visits ranged from 80.4 % of Guatemalan women to less than 20 % in Zambia. In the Indian sites, from 75 to 90 % of the women initiated ANC during the first trimester compared to less than 11 % of women initiating early ANC in the African sites. Around 50 % of the women in the Latin American sites initiated ANC in the first trimester. Physician delivery ranged from 74.6 % in Argentina to less than 3 % in both African sites. Women unattended during delivery, or attended by a family member only, ranged from <1 % in the Nagpur, Guatemalan and Argentinian sites to as many as The metrics of care varied by intervention and control cluster status for both antenatal care and delivery care. In Belgaum, India, measures of ANC tended to be better in the control clusters, while these measures were better in the intervention clusters in Nagpur, India. Few substantial differences in ANC between the intervention and control clusters were observed for other sites. In the Argentinian and both Indian sites, rates of physiciandelivery were higher in the control clusters compared to the intervention clusters, while Pakistan and Guatemala had higher physician-delivery rates in the intervention clusters. Both African sites had low rates (≤3 %) of physician delivery, which were similar across intervention groups. With the exception of the two African sites which had lower rates of hospital births among interventions clusters, the sites generally had higher rates of hospital deliveries in the intervention clusters compared to the control clusters (though differences in Argentina were negligible). In regard to the rates of hospital delivery, similar trends between the intervention and control clusters were observed in the sites during the pre-trial period (data now shown).
Across all sites, the use of ACS was substantially higher in the intervention compared to the control clusters (Table 3) .
The associations between being in the intervention clusters and 28-day neonatal mortality among the <5th percentile birth weight infants varied across sites. (Table 3 , Fig. 1 ) Overall the intervention was associated with no benefit or harmful effect on all < 5 th percentile infants, but a reduction in neonatal mortality among the <5th percentile birth weight infants in Guatemala (RR 0.75; 95 % CI 0.69-0.82) as well as Pakistan (RR 0.89; 95 % CI 0.80-0.99) (Fig. 2) . The experience of the Guatemala site, which showed the most favorable outcome, is described in detail elsewhere [Garces A, McClure EM, Figueroa L, et al.: A multi-faceted intervention including antenatal corticosteroids to reduce neonatal mortality associated with preterm birth: A case study from the Guatemalan Western Highlands, forthcoming].
For infants of all birth weights, across all sites the intervention compared to the control clusters was associated with a significant increase in the risk of neonatal death (RR 1 · 12, 95 % CI 1.02-1.22, p = 0.0127). When we stratified by site, this relationship was evident in the African sites: Zambia (RR 1.77; 95 % CI 1.42-2.20) and Kenya (RR 1.47; 95 % CI 1.02-2.12), and to a lesser extent in Nagpur, India (RR 1.36; 95 % CI 1.09-1.71). A marginally significant increase was also seen in Belgaum, India (RR 1.13; 95 % CI 0.99-1.27) ( Table 3 ; Fig. 2) . A significant association was not seen in the other sites.
We assessed the effect of being in the intervention compared to the control clusters on pSBI, adjusting for the pre-trial pSBI rates of the clusters. Being in the intervention clusters was associated with a statistically significant increase in pSBI in the African sites, Zambia (RR: 1.87; 95 % CI: 1.55-2.25) and Kenya (RR 1.90; 95 % CI 1.20-3.02). pSBI was not significantly associated with the intervention for the other sites. (Fig. 3) .
Discussion
ACT is a large randomized trial to assess a program aimed at increasing ACS use among women at risk of preterm birth. The trial sites represented diverse LMIC settings across Latin America, Asia and sub-Saharan Africa. While there was no overall benefit to being in the intervention group across the entire study, sites in Guatemala and Pakistan had a significantly lower neonatal mortality in the intervention compared to the Fig. 1 The RR of 28-day neonatal mortality among <5th percentile live births comparing the intervention to control clusters by site control clusters in the targeted (<5 th percentile) infants, while there was no evidence of benefit or harm in < 5 th percentile infants in the other sites.
Among all infants, the sites in Zambia, Kenya, and Belgaum and Nagpur (India) had a statistically or marginally significant increase in 28-day neonatal mortality in the intervention compared to the control clusters. The Zambian and Kenyan sites also had statistically significant increases in the risk of pSBI associated with the ACT intervention.
Considerable differences in ANC and obstetric care were found among the sites. Compared to the Asian and Latin American sites, the two sites in sub-Saharan Africa had substantially worse indicators of care. Few women delivered at a health facility, few deliveries were attended by a physician and the cesarean section rates were low.
Differences in care between the intervention and control clusters varied by site. While the clusters were stratified based on neonatal mortality rates prior to randomization, many of the differences in care observed between the intervention and control clusters appeared to precede the initiation of the ACT intervention. Overall, there were no clear patterns in the relationships between the outcomes and care when the intervention and control clusters were compared. For example, 28-day neonatal mortality was increased in the intervention clusters in Zambia despite increases in facility-based deliveries in those clusters. Similarly, the three sites with increased neonatal mortality had heterogeneous rates of skilled birth attendants at delivery. Kenya and Zambia had less care provided by traditional birth attendants or family birth attendants in the intervention compared to the control clusters, but an increase in overall neonatal mortality associated with the intervention. In the Pakistan site, where a slight benefit was associated with the intervention, no substantive differences in the processes of care were evident between the intervention and control clusters. 
Conclusions
Across all the sites there was no reduction in neonatal mortality in the <5 th percentile infants. However, Guatemala and to a lesser extent Pakistan had significant reductions in neonatal mortality in these infants. Guatemala, which had better indicators of care compared to some of the other sites and also in the intervention compared to the control clusters, showed benefit in the intervention compared to the control clusters in the targeted birth weight group. On the other hand, Kenya and Zambia showed a significant increase in neonatal mortality, as well as in suspected neonatal infection. Neonatal infection should be further investigated as a main outcome in future research studies.
These observations are intended as exploratory in nature and trends were not consistent across all sites. Because of the importance of identifying effective interventions to reduce neonatal mortality in the geographic areas with highest burden, further research is needed to define the impact of ACS across diverse settings in LMIC.
